Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Person-Centered Care for Opioid Use Disorder


 

Enhance Your Knowledge Regarding the Treatment of Opioid Use Disorder

 
This series will describe best practices regarding the use of supportive behavioral interventions and FDA-approved medications in Medication-Assisted Treatment (MAT) of opioid use disorder.  It will also address current controversies and ethical issues that sometimes come up in the treatment of opioid use disorder.  This learning opportunity is delivered from a multidisciplinary, team-based perspective, to better explain the successful outcomes that are attainable when a variety of healthcare professionals contribute to the patient-centered treatment process. This activity qualifies as 1 hour of opioid-related continuing pharmacy education.
 
FORMAT 
This program consists of multiple online self-paced modules.  Currently, there are not any additional live webinars scheduled.  
 
  • There is a Pre-Assessment Test that must be completed to access the remaining modules.  This assessment is not for a grade, but it is a primer for the content that will be covered in the upcoming modules.
  • There are 4 online modules, each consisting of a video-recorded lecture and interactive cases.
  • There are 3 live webinars that offer the opportunity to continue practice applying the course content with feedback from field experts.  (Note: currently there are not any additional webinars scheduled)
  • You will receive CE credit upon successful completion of each module. Successful completion includes viewing the module, earning 70% or better on the post-test (three attempts), and completing the online evaluation.   
  • You will receive CE credit upon successful completion of each webinar.  Successful completion includes participating in the full webinar and completing the evaluation that will be available after the webinar concludes.  Webinars will consist of 40-60 minutes of Q&A and case discussion.  Each webinar will be directly tied to its corresponding topic/module.  Be sure to complete the online module PRIOR to participating in its assigned webinar.  See complete details in the course outline below.  NOTE: Dates of webinars are subject to change based on faculty schedules, but prior notice will be provided to registrants.
  • See the link at the top of the page "View/Print CE Credit" to view your updated certificates or completed credits (CPE credits are automatically sent to the NABP profile in the learner's "My Profile" tab at the top right of this page).

Live Webinars - The live webinars have already taken place. Additional webinars are not scheduled at this time.

If you have already registered, and are looking to log in for the live webinars, be sure to click on the "Login" link at the top right-side of this page.  After logging in, click on the "pending programs" link at the top center, and find this course under the LIVE tab.  Click on the name of the course, then click on the Webinar 1 tab in the course.   Follow the instructions for connecting to the webinar.


Faculty

Lucas G. Hill, PharmD, BCPS, BCACP – Program Scientific Chair
Clinical Assistant Professor, College of Pharmacy
Director & Principal Investigator, Operation Naloxone

Caroline Hedenberg, LCSW
Collaborative Care Clinician, CARMAhealth

David Walsh, MSN, RN, PMHNP-BC
Chief Operations Officer, CARMAhealth

Carlos F. Tirado, MD, MPH
Chief Medical Officer, CARMAhealth
Clinical Associate Professor, Dell Medical School

Faculty Disclosures:

  • Lucas G. Hill, PharmD, BCPS, BCACP has no relevant financial interest to disclose.
  • Caroline Hedenberg, LCSW  has no relevant financial interest to disclose.
  • David Walsh, MSN, RN, PMHNP-BC has no relevant financial interest to disclose.
  • Carlos F. Tirado, MD, MPH is the Chief Medical Officer of CARMAhealth.

Fee

$0.00

CE Hours

6.50

CE Units

0.650

Activity Type

  • Knowledge

Target Audience(s)

  • Counselors
  • Pharmacists
  • Physician Assistant
  • Physicians
  • Psychologists
  • Social Workers

Requirements for CE Credit

ACPE Logo
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This knowledge-based CE activity consists of a series of online modules (3.5 CE hours) and live webinars (3.0 CE hours).  In order to receive CE credit for an online module, participants must successfully complete the pre-test (not for grade), view module content in its entirety, pass the post-test with a minimum score of 70% (three attempts), and completion of the module evaluation.  To earn CE credit for a live webinar, participants must attend the entire activity, participate in case exercises, and complete the online evaluation.

CME Credit:
The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine designates this enduring material for a maximum of 6.5 AMA PRA Category 1 CreditsTM.
This course has been designated by UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine for 6.50 credits of education in medical ethics and/or professional responsibility.

Social Work CEUs:
The University of Texas at Austin Hicks School of Social Work, Continuing Education Service has awarded 6.5 contact hour(s) of Continuing Social Work Education. Program represented by this certificate was provided in accordance with the criteria and standards of the Texas State Board of Social Worker Examiners, and has been approved for Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists. Please note that 1 hour = 1 CEU.  Complaints about this program may be made to TSBSWE, http://www.dshs.state.tx.us/socialwork/

Financial Disclosure:
This activity has been sponsored in-part through an educational grant from Alkermes, Inc.  Individual speaker disclosures are listed below, within their individual module description.

 

 

   

ONLINE MODULE START:  Pre-Assessment + Introduction to The Opioid Crisis
Pre-Assessment Test
 
The Pre-Assessment Test (which is not graded) must be completed FIRST, before viewing the Introduction or any other modules. The Pre-Assessment is intended to assess knowledge/perceptions before viewing any content.  Once completed, proceed with the Introduction below.
 
Introduction to the Opioid Crisis
 

Objectives

  • Describe recent national trends in opioid-related morbidity and mortality
  • Consider the unintended consequences of opioid supply reduction interventions

Activity Number

0067-0000-19-130-H01-P

Release Date: Sep 1, 2019
Credit Expiration Date: Sep 1, 2021

CE Hours

0.50
   

   

ONLINE MODULE 1: Supportive Behavioral Interventions
Complete this online self-paced module before participating in LIVE Webinar 1.
This module includes a 1-hour video, PDF copy of presentation slides, post-test, and evaluation for CE credit.  It follows the Flip Classroom design by requiring participants to complete this self-paced module before participating in LIVE Webinar 1.  Then the webinar will offer the opportunity to engage with the course presenter, ask questions, and work through case examples.   

Objectives

  • Describe key principles of SBIRT and MI
  • Identify supportive resources for clinical application of SBIRT and MI
  • Consider implementation of SBIRT and MI in OUD identification and treatment

Activity Number

0067-0000-19-131-H01-P

Release Date: Sep 1, 2019
Credit Expiration Date: Sep 1, 2021

CE Hours

1.00
   

   

ONLINE MODULE 2: Medication-Assisted Recovery 101
Complete this online self-paced module before participating in LIVE Webinar 2.
This module includes a 1-hour video, PDF copy of presentation slides, post-test, and evaluation for CE credit.  It follows the Flip Classroom design by requiring participants to complete this self-paced module before participating in LIVE Webinar 1.  Then the webinar will offer the opportunity to engage with the course presenter, ask questions, and work through case examples.
 
In this module, the faculty discusses three FDA-approved medications for OUD treatments, compares the basic pharmacology of these FDA-approved treatments, discribes evidence-based data of outcomes, contrasts barriers in accessing these treatments, and discusses the variables impacting these agents and treatments.

Objectives

  • Identify three FDA-approved medications for OUD treatment
  • Compare basic pharmacology of these agents and implications for treatment
  • Describe evidence regarding patient outcomes with these agents
  • Contrast barriers to accessing FDA-approved medications for OUD treatment
  • Consider the variable impact of these agents on access to recovery supports

Activity Number

0067-0000-19-133-H01-P

Release Date: Sep 1, 2019
Credit Expiration Date: Sep 1, 2021

CE Hours

1.00
   

   

ONLINE MODULE 3: Medication-Assisted Recovery 201 and Harm Reduction
Complete this online self-paced module before participating in LIVE Webinar 3.
This module includes a 1-hour video, PDF copy of presentation slides, post-test, and evaluation for CE credit.  It follows the Flip Classroom design by requiring participants to complete this self-paced module before participating in LIVE Webinar 1.  Then the webinar will offer the opportunity to engage with the course presenter, ask questions, and work through case examples.
 
In this module, the faculty discuss common comorbidities encountered in patients with sever OUD, describe team-based modules for comprehensive treatment of OUT as well as current controversies and ethical issues related to OUT treatment.  Further, they describe the role of naloxone in opioid overdose prevention, additional harm reduction interventions, and evaluate common myths regarding harm reduction interventions.

Objectives

  • Recall common comorbidities encountered in patients with sever OUD
  • Describe team-based models for comprehensive treatment of OUD and comorbidities
  • Discuss current controversies and ethical issues related to OUD treatment
  • Describe the role of naloxone in opioid overdose prevention
  • Discuss additional harm reduction interventions that can be implemented in healthcare settings
  • Evaluate common myths regarding harm reduction interventions

Activity Number

0067-0000-19-135-H01-P

Release Date: Sep 1, 2019
Credit Expiration Date: Sep 1, 2021

CE Hours

1.00
   

   

LIVE WEBINAR 1: Supportive Behavioral Interventions - ALREADY COMPLETED
The live webinar for ONLINE MODULE 1: Supportive Behavioral Interventions took place on 10/21/19.  Therefore, this session is no longer available for CE credit.  However, the recorded content is available for viewing. 

Activity Number

0067-0000-19-132-H01-P
Date: 10/21/19
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
   

   

LIVE WEBINAR 2: Medication Assisted Recovery 101- ALREADY COMPLETED 
The live webinar for ONLINE MODULE 2: Medication Assisted Recovery 101 took place on 12/16/19.  Therefore, CE credit is no longer available for this content. However, the recorded content is available for learning purposes, not for CE credit.
Faculty:
Lucas G. Hill, Pharm.D
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
Disclosure: Dr. Hill has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
 
David Walsh, MSN, RN, PMHNP-BC
Chief Operations Officer, CARMAhealth
Disclosure: David Walsh has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

 

Activity Number

0067-0000-19-134-H01-P
Date: 12/16/19
Time: 12:00 PM - 01:00 PM

CE Hours

1.00
   

   

LIVE WEBINAR 3: Medication Assisted Recovery 201 and Harm Reduction - ALREADY COMPLETED
The live webinar for ONLINE MODULE 3: Medication Assisted Recovery 201 took place on 12/21/19. Therefore, CE credit is no longer available.  However, the recorded content is available for learning purposes only, not for CE credit.
 
 
Webinar Faculty:
 
Lucas G. Hill, PharmD, BCPS, BCACP
Clinical Assistant Professor, College of Pharmacy
Director & Principal Investigator, Operation Naloxone
Disclosure: Dr. Hill has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
 
Carlos F. Tirado, MD, MPH
Chief Medical Officer, CARMAhealth
Clinical Associate Professor, Dell Medical School
Disclosure: Dr. Tirado has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-19-136-H01-P
Date: 12/20/19
Time: 12:00 PM - 01:00 PM

CE Hours

1.00